Pediatric Endocrinology & Diabetes Research
Investigators in NYU Langone’s Division of Pediatric Endocrinology and Diabetes have diverse areas of interest and engage in a wide range of research activities. Their work is published in numerous peer-reviewed journals, and division members frequently deliver lectures at scientific conferences and other academic medical centers.
Research in the division focuses on pediatric diabetes and pediatric disorders that affect growth, the adrenal glands, and the pituitary gland. Investigators study the effects of medications and vitamins on the pediatric endocrine system, including hypercalcemia and problems with growth. Researchers have also studied the adverse effects of growth hormone therapies for puberty induction.
The investigators have studied geographic disparities in diabetes prevalence, as well as cortisol levels in children with diabetic ketoacidosis at diagnosis of new-onset type 1 diabetes mellitus. The division has been involved in the development of guidelines for children and adolescents with thyroid cancer.
Pharmacologic Weight Management in the Era of Adolescent Obesity
Journal of clinical endocrinology & metabolism. 2022 Sep 28; 107:2716-2728
Visceral adiposity is related to insulin sensitivity and inflammation in adolescents with obesity and mild sleep disordered breathing
Journal of pediatric endocrinology & metabolism. 2022 Aug 26; 35:1069-1077
Comorbidities increase COVID-19 hospitalization in young people with type 1 diabetes
Pediatric diabetes. 2022 Aug 17;
Trends in type 1 diabetic ketoacidosis during COVID-19 surges at seven US centers: highest burden on non-Hispanic Blacks
Journal of clinical endocrinology & metabolism. 2022 Jun 16; 107:1948-1955
Increase in newly diagnosed type 1 diabetes in youth during the COVID-19 pandemic in the US: A multi-center analysis
Pediatric diabetes. 2022 Jun ; 23:433-438
Cardiovascular health in emerging adults with type 1 diabetes
European journal of cardiovascular nursing. 2022 Apr 09; 21:213-219
Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study
Journal of clinical endocrinology & metabolism. 2022 01 18; 107:410-418
Differences in COVID-19 Outcomes among Patients with Type 1 Diabetes: First vs Later Surges
Journal of clinical outcomes management. 2022 Jan 01; 29:27-31